GLP-1 drugs commonly cause nausea, constipation, or an uncomfortable sense of fullness, especially early on, because they slow digestion
Mental health and quality of life in different obesity phenotypes: a systematic review
Structure of PEG Loxenatide Tirzepatide Tirzepatide is a dual GIP/GLP-1 receptor agonist that activates both the GLP-1 and GIP signaling pathways
That is comparable to results achieved by taking the highest dose of Lillys other blockbuster weight loss drug, Zepbound
"The decreases we saw will likely show up in a much broader slice of the population" because of weight-loss pills, said Sylvia Hristakeva, one of the study's co-authors
Readers are encouraged to verify all details directly with ColonBroom and their healthcare provider before making decisions